The @LCGeneticsStudy is getting stronger! New technology partnership announcement marks a major step forward. Encourage anyone diagnosed in the US to take part.
Learn more:
https://t.co/yDHYBLIiIk
#LCSM
Fantastic to see the next step in the @LCGeneticsStudy. They've teamed up with @lifebitAI to build a new secure platform to help analyse data from 10,000 lung cancer patients by 2027.
If you've been diagnosed with lung cancer, you can help too!
More at👇
https://t.co/qXENUUMeyD
Today's announcement marks a major step forward for the @23andMe Lung Cancer Genetics Study! A new secure platform will help approved non-profit researchers access and analyze data from 10,000 participants at no cost.
Read the full story: https://t.co/qUCzpI5gjD #LCSM
Proud that the Israeli Genomic Medicine Initiative Psifas has chosen @lifebitAI
Empowering advancements in personalised medicine by providing a secure & unified platform for clinical-genomic research across Israel’s diverse population
https://t.co/O2vgkP6qTY #genomics#tre
News! @23andMe has chosen @lifebitAI's leading Trusted Research Environment to enable external research partners identify novel disease biology, discover potential new drug targets, & add genetic evidence into research programs to boost clinical success https://t.co/HHtboPT923
Introducing our Lifebit Clinical Portal v2! With advanced AI and seamless EHR & genomic data integration, this platform leads the way in precision medicine for healthcare. Visit @lifebitAI's blog to understand how we’re driving better health outcomes: https://t.co/t7syfxfmew
Effective patient recruitment and enrollment are vital for clinical trials. @lifebitAI's latest blog highlights innovative solutions to enhance efficiency and diversity. Streamline processes, cut costs and speed up drug approvals: https://t.co/8Ur6W0qJ5w #Lifebit